Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All

Novel findings in cancer stem cells research and therapy

Journal: Cancer Plus
Submission Deadline: 12 March 2026
Special Issue Editor
Tanja Matijevic Glavan
Laboratory for Personalized Medicine, Division of Molecular Medicine, Rudjer Boskovic Institute, Zagreb, Croatia
Interests:

Cancer, cancer stem cells, chronic inflammation, oxidative stress, cancer therapy, radiation therapy, cell death

Profile:

Tanja Matijevic Glavan is a researcher at the Ruđer Bošković Institute in Zagreb, Croatia. Her work focuses on molecular biology and biomedical research, with particular interest in cancer biology and genomic analysis.

Special Issue Information

Cancer stem cells (CSCs) are a small subpopulation of cells within a tumor that have properties similar to normal stem cells. That means they are capable of self-renewal and can generate different types of cells found in a specific cancer. This makes them highly tumorigenic, meaning they are a key driver of tumor growth, and they are believed to be responsible for cancer initiation, recurrence, and metastasis. In this special issue we will present novel findings on cancer stem cells with special emphasis on innovative therapies, especially repurposing existing drugs and using phytonutrients for targeting cancer stem cells. 

Back to top
Cancer Plus, Electronic ISSN: 2661-3840 Print ISSN: 2661-3832, Published by AccScience Publishing